Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Adv Hematol Oncol. 2011 Dec;9(12):925-6.

Ponatinib: targeting the T315I mutation in chronic myelogenous leukemia.

Author information

  • Department of Hematology/Oncology, University of California-San Francisco, San Francisco, California, USA.
PMID:
22252660
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk